Dr. Alberto Ascherio of Harvard and Dr. Stephen Hauser of the University of California, San Francisco (UCSF) — will share $3 ...

Hauser frets that amid federal cutbacks, young scientists may turn away from medical research, knee-capping health care ...

A new study suggests that high doses of vitamin D supplements could help reduce disease activity among multiple sclerosis ...

An American neurologist and an Italian epidemiologist whose work revolutionized the treatment of multiple sclerosis on ...

Fooling others — and himself — into believing his MS symptoms weren't a big deal wasn't a good approach, writes columnist Be.

Alberto Ascherio and Stephen Hauser were recognized for their work uncovering the role of B cells and Epstein Barr virus in ...

Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients ...

No added benefits in slowing MS disability progression were found in a study that increased Ocrevus dosing to 2-3 times the ...

An American neurologist and an Italian epidemiologist whose work revolutionised the treatment of multiple sclerosis yesterday ...

Roche said on Wednesday that a trial testing higher doses of its multiple sclerosis drug Ocrevus did not show an efficacy ...

Multiple Sclerosis: Cell-Catching Implant Helps Identify Successful Treatment in Mice Feb. 18, 2025 — A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative ...